Login
Existing Account

Please login first to complete purchase/ quotation request, view custom order reports, or create favorites list.

Customer ID:
Password:
Stay Logged In


Forgot your Customer ID or Password?
New Account

Don't have an account with us yet? Please set up an account to place order or obtain customer services.

Account Login My Cart My Custom Reports My Favorites Logout
About AnaSpec Ordering & Shipping Technical Notes contact us
Smart Search
Peptides
Fluorescent Dyes & Quenchers
SensoLyte® Assay Kits
Antibodies
AnaTag? Protein Labeling Kits
Enzymes and Other Proteins
Amino Acids
Synthesis Reagents, Resins & Accessories
qPCR & qRT-PCR Reagents
Oligonucleotides
Cloning & Expression and Gene Analysis
Subscribe to AnaSpec Announcements
Email:
Research Topics

Peptides  >  Myelin Oligodendrocyte Glycoprotein (MOG)/Myelin Basic Proteins (MBP)  >>  MOG (35-55), mouse, rat
Product Name MOG (35 - 55), mouse, rat
Size 1 mg
Catalog # 60130-1
US$ $140
Purity % Peak Area By HPLC ≥ 95%
Description

This peptide* induced anti-MOG(35-55) autoantibody production in C57BL/6 mice with 100% incidence (10/10); providing quantitative support for the suitability of the MOG peptide for in vivo anti-MOG(35-55) autoantibody study. Cysteine containing MOG (35-55) peptide induced polyclonal anti-MOG(35-55) antibody production in rabbits with high specificity, high affinity, and high titer indicating its high purity, as well as suitability for peptide-coated ELISA and Western blot assay. Using this mouse/rat MOG (35-55) peptide as a coating peptide, AnaSpec produced the industry’s first anti-MOG (35-55) ELISA kit for EAE study. The detection limit was measured to be as low as 50 pg of anti-MOG (35-55) autoantibody in serum or cerebrospinal fluid. After testing different lots of AnaSpec MOG peptides for ELISA coating, AnaSpec reported that the quality variation from lot to lot was minimal.
*Tested for lot# 61918 & 71369
Detailed Information Datasheet
Flyer
Storage -20°C
Molecular Weight 2582
Sequence
(One-Letter Code)		 MEVGWYRSPFSRVVHLYRNGK
Sequence
(Three-Letter Code)		 H - Met - Glu - Val - Gly - Trp - Tyr - Arg - Ser - Pro - Phe - Ser - Arg - Val - Val - His - Leu - Tyr - Arg - Asn - Gly - Lys - OH
Product Citations Zhao, YG. et al. (2012). Dihydroartemisinin ameliorates inflammatory disease by its reciprocal effects on Th and regulatory T cell function via modulating the mammalian target of rapamycin pathway. J Immunol, 189, 4417.
Polak, P. et al. (2011). Locus coeruleus damage and noradrenaline reductions in multiple sclerosis and experimental autoimmune encephalomyelitis. Brain 10.1093/brain/awq362.
Shohreh, R. et al. (2011). GH, but not GHRH, plays a role in the development of experimental autoimmune encephalomyelitis. Endocrinology 10.1210/en.2011-1317.
Aizman, E. et al. (2010). The combined treatment of Copaxone and Salirasib attenuates experimental autoimmune encephalomyelitis (EAE) in mice. J Neuroimmunol 229, 192.
Simonini, MV. et al. (2010). Increasing CNS noradrenaline reduces EAE severity. J Neuroimmune Pharmacol 5, 252.
Simonini, M. et al. (2010). Regulation of oligodendrocyte progenitor cell maturation by PPARδ: effects on bone morphogenetic proteins. ASN Neuro 10.1042/AN20090033.
Toscano, MG. et al. (2010). Dendritic cells transduced with lentiviral vectors expressing VIP differentiate into VIP-secreting tolerogenic-like DCs. Mol Ther 18, 1035.
Kawasaki, T. et al. (2009). A minimal regulatory domain in the C terminus of STIM1 binds to and activates ORAI1 CRAC channels. Biochem Biophys Res Commun 385, 49.
Li, Q. et al. (2009). Augmenting DAF levels in vivo ameliorates experimental autoimmune encephalomyelitis. Mol Immunol 46, 2885.
Li, Q. et al. (2009). The complement inhibitor FUT-175 suppresses T cell autoreactivity in experimental autoimmune encephalomyelitis. Am J Pathol 175, 661.
Guo, B. et al. (2008). The type 1 IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice. J Clin Invest 118, 1680.
Sharp, AJ. et al. (2008). P2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis. J Neuroinflammation 10.1186/1742-2094-5-33.
Frausto, RF. et al. (2007). Myelin oligodendrocyte glycoprotein peptide-induced experimental allergic encephalomyelitis and T cell responses are unaffected by immunoproteasome deficiency. J Neuroimmunol 192, 124.
     
  < Back
Copyright © 2002-2011 AnaSpec, Inc. All rights reserved. | 65.39.186.246 (USA) | Site Map | Terms & Conditions